The data so far has been strong enough that the medical community is paying close attention, and so are patients who haven't found success with previous treatments
Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated cardiovascular and kidney benefits in the general population with type 2 diabetes mellitus (T2DM), evidence regarding their effects in diabetic KTRs is limited
Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial
You can even set a reminder on your phone to make it easy to remember
Discussion In the present study, we found that GLP-1R protein levels decreased significantly in a knee OA rat model induced by monoiodoacetate, which was accompanied by the downregulation of the PKA/CREB pathway and upregulation of the inflammation-related proteins TNF-, IL-6 and IL-1
Precauciones: No recomendable para menores de 15 aos, en embarazo, ni lactancia